← Back to Search

Oncology Nurse Navigation for Gastrointestinal Cancer (ACCESS Trial)

N/A
Waitlist Available
Led By Mohamed Salem, MD
Research Sponsored by Mohamed Salem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- Metastatic/recurrent or locally advanced, unresectable hepatocellular carcinoma (HCC)
Treatment naïve OR adjuvant greater than 6 months ago, histologically or cytologically confirmed one of the following diagnoses (metastatic/recurrent status can be radiologically confirmed):
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the date of randomization up until 12 months
Awards & highlights

ACCESS Trial Summary

This trial looks at whether a specific type of cancer care coordination can reduce the number of times patients need to go to the emergency room or be hospitalized, and whether it improves survival rates.

Eligible Conditions
  • Gastrointestinal Cancer

ACCESS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have liver cancer that has spread to other parts of the body or has come back after treatment, and it cannot be surgically removed.
Select...
You have been diagnosed with one of the following diseases, either recently or more than 6 months ago, and it has been confirmed by tests: [list of diseases].
Select...
You have pancreatic cancer that has spread to other parts of the body, come back after treatment, or is in a state where it cannot be surgically removed.
Select...
You have advanced or recurring cancer in the esophagus, gastroesophageal junction, or stomach, and surgery is not an option for you.
Select...
You are expected to live for more than 3 months.

ACCESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the date of randomization up until 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the date of randomization up until 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Care Utilization
Overall Survival
Secondary outcome measures
Oncology Nurse Navigation Comparison Hospice
Oncology Nurse Navigation Comparison Hospital Stay
Oncology Nurse Navigation Comparison Overall Survival
+4 more
Other outcome measures
Oncology Nurse Navigation Provider Comparison for Outcomes

ACCESS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Oncology Nurse NavigationExperimental Treatment1 Intervention
Standard of Care + Oncology Nurse Navigation
Group II: Standard of CareActive Control1 Intervention
Standard of Care

Find a Location

Who is running the clinical trial?

Mohamed SalemLead Sponsor
Wake Forest University Health SciencesLead Sponsor
1,231 Previous Clinical Trials
1,001,573 Total Patients Enrolled
Mohamed Salem, MD4.52 ReviewsPrincipal Investigator - Wake Forest University Health Sciences
Atrium Health
1 Previous Clinical Trials
4 Total Patients Enrolled
4Patient Review
Stephanie Arbogast is an excellent professional.

Media Library

Oncology Nurse Navigation Clinical Trial Eligibility Overview. Trial Name: NCT04602611 — N/A
Gastrointestinal Cancer Research Study Groups: Standard of Care, Oncology Nurse Navigation
Gastrointestinal Cancer Clinical Trial 2023: Oncology Nurse Navigation Highlights & Side Effects. Trial Name: NCT04602611 — N/A
Oncology Nurse Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04602611 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What aims is this clinical trial trying to achieve?

"The primary goal of this trial, measured over a period of 6 months from when the patient was randomized until they cease treatment, is to observe Overall Survival. Supporting outcomes are Oncology Nurse Navigation Comparison for Overall Survival (rate and at 12 months), Oncology Nurse Navigation Comparison for Satisfaction (#33 EORTC PATSAT C33 scale 1-5; higher scores indicate better results) and finally Oncology Nurse Navigation Referral Rate which measures referral rate towards Palliative Care services, Hospice aid, Nutrition support as well as Social Work Services."

Answered by AI

Are there currently vacancies to become a participant in this research?

"The information on clinicaltrials.gov reveals that this medical study is actively recruiting participants at the present time. The trial was initially posted in November of 2020 and last modified on October 5th 2022."

Answered by AI

How many participants are being monitored in this clinical assessment?

"Affirmative. According to the information retrievable from clinicaltrials.gov, this medical study is open for recruitment and was initially surfaced on 3rd November 2020 with its most recent update occurring on 5th October 2022. The trial seeks 214 participants at a single site of operation."

Answered by AI
~55 spots leftby Mar 2025